Indraprastha Apollo Hospital is an Indian hospital owned by Apollo Hospital group, India's largest healthcare chain, and is the second largest money making hospital in Delhi. This hospital was established in 1995.

During the past decade, Indraprastha Apollo Hospitals conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 15 clinical trials were completed, i.e. on average, 88.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indraprastha Apollo Hospitals" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Fungal Infection Study Forum" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indraprastha Apollo Hospitals" #1 collaborator was "Aalborg University Hospital" with 1 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator, "Apollo Hospital, New Delhi, India" with 1 trials as a collaborator, "Apollo Hospitals Enterprise Limited" with 1 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Indraprastha Apollo Hospitals" are "Breast Cancer" (3 trials), "Anemia" (2 trials), "Mycoses" (2 trials), "Pulmonary Arterial Hypertension" (2 trials) and "Acute Myocardial Infarction (AMI)" (1 trials). Many other conditions were trialed in "Indraprastha Apollo Hospitals" in a lesser frequency.

Most popular intervention types in "Indraprastha Apollo Hospitals" are "Drug" (28 trials), "Other" (4 trials), "Biological" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Paclitaxel" (2 trials), "Trastuzumab" (2 trials), "placebo" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Indraprastha Apollo Hospitals" are 34 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Indraprastha Apollo Hospitals". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Indraprastha Apollo Hospitals, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Indraprastha Apollo Hospitals, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 0 trials that are defined as “Not Applicable".